GAIBANI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 6.515
AS - Asia 5.822
EU - Europa 4.125
Continente sconosciuto - Info sul continente non disponibili 386
AF - Africa 379
SA - Sud America 360
OC - Oceania 21
Totale 17.608
Nazione #
US - Stati Uniti d'America 6.363
SG - Singapore 1.562
VN - Vietnam 1.519
CN - Cina 1.476
IT - Italia 1.009
GB - Regno Unito 786
SE - Svezia 548
DE - Germania 498
HK - Hong Kong 349
BR - Brasile 256
IN - India 240
FR - Francia 220
RU - Federazione Russa 204
NL - Olanda 155
KR - Corea 150
IE - Irlanda 147
UA - Ucraina 138
FI - Finlandia 119
ZA - Sudafrica 118
BD - Bangladesh 110
CI - Costa d'Avorio 110
JP - Giappone 104
CA - Canada 74
CH - Svizzera 61
ID - Indonesia 49
TG - Togo 49
BG - Bulgaria 45
EE - Estonia 42
PH - Filippine 42
AR - Argentina 41
JO - Giordania 41
NG - Nigeria 37
MX - Messico 30
PK - Pakistan 30
IQ - Iraq 26
BE - Belgio 23
SC - Seychelles 23
AT - Austria 21
TH - Thailandia 21
TW - Taiwan 20
PL - Polonia 18
TR - Turchia 18
ES - Italia 16
RO - Romania 16
AU - Australia 15
CO - Colombia 14
LT - Lituania 12
SA - Arabia Saudita 11
EC - Ecuador 10
IR - Iran 9
MY - Malesia 9
PE - Perù 9
CL - Cile 8
HR - Croazia 8
JM - Giamaica 8
PT - Portogallo 8
VE - Venezuela 8
PY - Paraguay 7
TN - Tunisia 7
CR - Costa Rica 6
GR - Grecia 6
HN - Honduras 6
LB - Libano 6
TT - Trinidad e Tobago 6
AZ - Azerbaigian 5
UZ - Uzbekistan 5
CZ - Repubblica Ceca 4
DZ - Algeria 4
EG - Egitto 4
ET - Etiopia 4
IL - Israele 4
NZ - Nuova Zelanda 4
RS - Serbia 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
KZ - Kazakistan 3
LI - Liechtenstein 3
NI - Nicaragua 3
PA - Panama 3
PR - Porto Rico 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
UY - Uruguay 3
ZW - Zimbabwe 3
AL - Albania 2
BH - Bahrain 2
DK - Danimarca 2
HT - Haiti 2
KG - Kirghizistan 2
LY - Libia 2
NO - Norvegia 2
YT - Mayotte 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
CM - Camerun 1
Totale 17.196
Città #
Singapore 1.069
Ashburn 754
Southend 674
Fairfield 492
Chandler 426
San Jose 394
Santa Clara 333
Hong Kong 331
Ho Chi Minh City 323
Hanoi 289
Hefei 268
Woodbridge 247
Seattle 237
Wilmington 213
Dong Ket 212
Houston 210
Princeton 194
Cambridge 179
Beijing 176
Council Bluffs 169
Boardman 155
Dublin 145
Ann Arbor 141
New York 121
Seoul 119
Bologna 117
Abidjan 110
Los Angeles 100
Lauterbourg 96
Helsinki 95
Jacksonville 87
Tokyo 87
Nanjing 75
Padova 75
Westminster 63
Dallas 61
Milan 58
Rome 57
Buffalo 53
Bern 50
Berlin 49
Bremen 49
Lomé 49
Jinan 47
Sofia 45
Chicago 43
Da Nang 42
Guangzhou 42
Amman 41
Redwood City 41
São Paulo 40
Saint Petersburg 39
Shanghai 39
Turin 39
Pretoria 38
Redondo Beach 37
San Diego 37
Hangzhou 35
Frankfurt am Main 34
Haiphong 34
Munich 33
Mülheim 32
Abeokuta 31
Jakarta 31
Phoenix 30
Florence 28
Changsha 27
Tianjin 26
Bengaluru 24
Des Moines 24
London 24
Nanchang 24
Shenyang 24
Verona 24
Toronto 23
Falls Church 22
Hebei 22
Brussels 21
Nuremberg 21
Biên Hòa 19
Falkenstein 18
Lappeenranta 18
Montreal 18
Atlanta 17
Redmond 17
Hải Dương 16
Jiaxing 16
Ningbo 16
Zhengzhou 16
Tappahannock 15
Brooklyn 14
San Francisco 14
Can Tho 13
Denver 13
Johannesburg 13
Olalla 13
Quận Bình Thạnh 13
Yubileyny 13
Amsterdam 12
Genoa 12
Totale 10.682
Nome #
A rapid and specific real-time RT-PCR assay to identify Usutu virus in human plasma, serum, and cerebrospinal fluid 282
Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically. 263
Infections in liver and lung transplant recipients: A national prospective cohort 255
New evidence of cutaneous leishmaniasis in north-eastern Italy 254
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 253
Molecular remodeling of potassium channels in fibroblasts from centenarians: a marker of longevity? 249
Comparative genomic and phylogenetic analysis of the first usutu virus isolate from a human patient presenting with neurological symptoms. 248
Carbapenem resistant bacteria in Intensive Care Unit during COVID-19 pandemic: Multicenter before-after cross sectional study 242
Persistence of anti-west nile virus-specific antibodies among asymptomatic blood donors in Northeastern Italy. 238
Serological and molecular tools to diagnose visceral leishmaniasis: 2-years' experience of a single center in Northern Italy 235
Ceftolozane-Tazobactam Treatment of Hypervirulent Multidrug Resistant Pseudomonas aeruginosa Infections in Neutropenic Patients 231
In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment 226
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study 226
Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19 223
Toscana virus infections in northern Italy: laboratory and clinical evaluation. 218
The central region of the msp gene of Treponema denticola has sequence heterogeneity among clinical samples, obtained from patients with periodontitis 212
Chikungunya: an emerging and spreading arthropod-borne viral disease. 206
Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study 203
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam for treating DTR gram-negative infections in a case series of critically ill patients undergoing continuous veno-venous haemodiafiltration (CVVHDF) 202
Detection of Usutu-virus-specific IgG in blood donors from northern Italy 202
Clinical application of Bruker Biotyper MALDI-TOF/MS system for real-time identification of KPC production in Klebsiella pneumoniae clinical isolates 194
COVID-19 in patients with HIV-1 infection: a single-centre experience in northern Italy 191
Bloodstream infection caused by KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam: epidemiology and genomic characterization 190
Resistance to Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam in Gram-Negative MDR Bacilli: Molecular Mechanisms and Susceptibility Testing 189
Whole Genome Sequencing of a Chlamydia trachomatis Strain Responsible for a Case of Rectal Lymphogranuloma Venereum in Italy 189
Inflammatory cytokine expression is associated with chikungunya virus resolution and symptom severity. 186
Killing of Treponema denticola by mouse peritoneal macrophages. 185
Diagnosis of west nile virus human infections: overview and proposal of diagnostic protocols considering the results of external quality assessment studies. 185
Antiviral activity of interferon-based combination therapy in critically ill patients with COVID-19: Preliminary observations 181
Blood culture systems: rapid detection-how and why? 179
Pharmacokinetics/pharmacodynamics of cefiderocol administered by continuous infusion in a case series of critically ill patients with carbapenem-resistant Acinetobacter baumannii infections undergoing continuous venovenous haemodiafiltration (CVVHDF) 177
Single-reaction, multiplex, real-time rt-PCR for the detection, quantitation, and serotyping of dengue viruses. 175
Successful Treatment of Bloodstream Infection due to a KPC-Producing Klebsiella Pneumoniae Resistant to Imipenem/Relebactam in a Hematological Patient 173
Treponema Denticola alters cell vitality and induces HO1 and HSP70 expression in porcine Aortic Endothelial cells. 173
A carbapenem-resistant Klebsiella pneumoniae isolate harboring KPC-1 from Italy. 173
Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant Pseudomonas aeruginosa Bloodstream Infections and/or Hospital-Acquired Pneumonia 172
A novel method to evaluate ceftazidime/avibactam therapy in patients with carbapenemase-producing Enterobactericeae (CPE) bloodstream infections 171
Evaluation of Phenotypic and Genotypic Approaches for the Detection of Class A and Class B Carbapenemases inEnterobacteriaceae 170
Comparative Usutu and West Nile virus transmission potential by local Culex pipiens mosquitoes in north-western Europe 169
Comparative serum bactericidal activity of meropenem-based combination regimens against extended-spectrum beta-lactamase and KPC-producing Klebsiella pneumoniae 169
Imported cases of dengue virus infection: Emilia-Romagna, Italy, 2010. 168
Human infection with highly pathogenic a(H7N7) avian influenza virus, Italy, 2013 166
Phylogenetic analysis of West Nile virus isolates, Italy, 2008-2009. 164
False-positive transcription-mediated amplification assay detection of West Nile virus in blood from a patient with viremia caused by an Usutu virus infection. 162
Outbreak of Citrobacter freundii carrying VIM-1 in an Italian Hospital, identified during the carbapenemases screening actions, June 2012. 161
Two cases of relapsed HIV-associated visceral leishmaniasis successfully treated with combination therapy 160
Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in Candida spp colonized patients 160
In vitro interaction of ceftazidime–avibactam in combination with different antimicrobials against KPC-producing Klebsiella pneumoniae clinical isolates 159
Carbapenemase-producing Enterobacterales: changing epidemiology in a highly endemic Italian area 158
The Gut Microbiota of Critically Ill Patients With COVID-19 158
A descriptive case series of PK/PD target attainment and microbiological outcome in critically ill patients with documented severe XDR Acinetobacter baumannii BSI and/or VAP treated with cefiderocol 157
Complete genome sequence and antimicrobial resistance analysis of ESBL-producing Shigella sonnei carrying small cryptic plasmids isolated in northern Italy. 156
Mosquito, bird and human surveillance of west nile and usutu viruses in Emilia-Romagna region (Italy) in 2010. 156
Heterogeneity of West Nile virus genotype 1a in Italy, 2011 155
A novel IncA plasmid carrying blaVIM-1 in a Kluyvera cryocrescens strain 154
Seroprevalence of West Nile virus-specific antibodies in a cohort of blood donors in northeastern Italy 153
Microbiological and pharmacological tests on new antibiotic-loaded PMMA-based composites for the treatment of osteomyelitis 153
Respiratory bacterial co-infections in intensive care unit-hospitalized COVID-19 patients: Conventional culture vs BioFire FilmArray pneumonia Plus panel 153
Comparison of Broth Microdilution, Disk Diffusion and Strip Test Methods for Cefiderocol Antimicrobial Susceptibility Testing on KPC-Producing Klebsiella pneumoniae 152
Genome characterization of a Klebsiella pneumoniae co-producing OXA-181 and KPC-121 resistant to ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam and cefiderocol isolated from a critically ill patient 152
Epidemiology and In Vitro Activity of Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam against KPC-Producing K. pneumoniae Collected from Bacteremic Patients, 2018 to 2020 151
Development of a broad-range 23S rDNA real-time PCR assay for the detection and quantification of pathogenic bacteria in human whole blood and plasma specimens. 149
Diagnostic methods for CHIKV based on serological tools 146
Detection of specific antibodies against West Nile and Usutu viruses in healthy blood donors in northern Italy, 2010-2011. 145
Clinical application of a molecular method based on real time RT-PCR for detection od influenza A(H1N1)v 145
The experience of West Nile virus integrated surveillance system in the Emilia-Romagna region: five years of implementation, Italy, 2009 to 2013 145
Serum bactericidal titres for monitoring antimicrobial therapy: current status and potential role in the management of multidrug-resistant Gram-negative infections 144
Effect of incremental tazobactam concentrations on the bactericidal activity of piperacillin against ESBL-producing enterobacterales clinical isolates causing bacteraemia 142
Outbreak of NDM-1-producing Enterobacteriaceae in northern Italy, July to August 2011. 141
Clinical consequences of very major errors with semi-automated testing systems for antimicrobial susceptibility of carbapenem-resistant Enterobacterales 140
Major surface protein complex of Treponema denticola induces the production of tumor necrosis factor alpha, interleukin-1beta, interleukin-6 and matrix metalloproteinase 9by primary human peripheral blood monocytes. 137
Retrospective screening of solid organ donors in Italy, 2009, reveals unpredicted circulation of West Nile virus. 136
Real-Time Optimization of Pharmacodynamic Target Attainment at Infection Site during Treatment of Post-Neurosurgical Ventriculitis Caused by Carbapenem-Resistant Gram Negatives with Ceftazidime–Avibactam-Based Regimens: A Report of Two Cases 136
Novel CMY-186 variant conferring cross-resistance to cefiderocol and ceftazidime/avibactam in Klebsiella pneumoniae from a critically ill patient during cefiderocol and ceftazidime/avibactam treatment 133
Colonization by ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae following therapy in critically ill patients 133
Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of KPC-producing Klebsiella pneumoniae 133
Successful Treatment of Bacteremia and Ventilator-Associated Pneumonia Caused by KPC/OXA-48-like Klebsiella pneumoniae Co-Producer with a Continuous Infusion of High-Dose Meropenem Plus Fosfomycin Guided by Real-Time Therapeutic Drug Monitoring 132
Serodiagnosis of visceral leishmaniasis in northeastern italy: Evaluation of seven serological tests 131
Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Northern Italy, 2018 130
Draft Genome Sequences of Two Multidrug Resistant Klebsiella pneumoniae ST258 Isolates Resistant to Colistin. 128
Suboptimal drug exposure leads selection of different subpopulations of ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae in a critically ill patient 126
Persistence of anti-chikungunya virus-specific antibodies in a cohort of patients followed from the acute phase of infection after the 2007 outbreak in Italy. 124
Rectal screening of carbapenemase-producing Enterobacteriaceae: a proposed workflow 124
West Nile virus circulation in Emilia-Romagna, Italy: the integrated surveillance system 2009. 123
Clonal Dissemination of Candida auris Clinical Isolates in Northern Italy, 2021 122
In vivo emergence of cefiderocol and ceftazidime/avibactam cross-resistance in KPC-producing Klebsiella pneumoniae following ceftazidime/avibactam -based therapies 121
Draft Genome of Klebsiella pneumoniae Sequence Type 512, a Multidrug-Resistant Strain Isolated during a Recent KPC Outbreak in Italy. 115
Humans parasitized by the hard tick Ixodes ricinus are seropositive to Midichloria mitochondrii: is Midichloria a novel pathogen, or just a marker of tick bite? 115
Rapid increase of carbapenemase-producing Klebsiella pneumoniae strains in a large Italian hospital: surveillance period 1 March - 30 September 2010. 114
Dynamic evolution of imipenem/relebactam resistance in a KPC-producing Klebsiella pneumoniae from a single patient during ceftazidime/avibactam-based treatments 111
Do mosquito-associated bacteria of the genus Asaia circulate in humans? 110
Clonal dissemination of Klebsiella pneumoniae resistant to cefiderocol, ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam co-producing KPC and OXA-181 carbapenemase 109
Pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam in peritoneal fluid in an orthotopic liver transplant recipient affected by bacteraemic complicated intra-abdominal infection: due to OXA-181-producing Klebsiella pneumoniae 109
Usutu virus infection in a patient who underwent orthotropic liver transplantation, Italy, August- September 2009. 109
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion meropenem/vaborbactam in the treatment of critically ill patients with documented KPC-producing Klebsiella pneumoniae ventilator-associated pneumonia 108
Successful containment and infection control of a Carbapenem-resistant Klebsiella pneumoniae outbreak in an Italian hospital 108
Phenotypic and genotypic characterization of Klebsiella pneumoniae strains with reduced susceptibiliy to carbapenems 106
Detection of West Nile virus RNA (lineages 1 and 2) in an external quality assessment programme for laboratories screening blood and blood components for West Nile virus by nucleic acid amplification testing. 105
Evaluation of five carbapenemase detection assays for Enterobacteriaceae harbouring bla KPC variants associated with ceftazidime/avibactam resistance 103
Evaluation of synergistic activity of fosfomycin in combination with novel ß-lactams/ß-lactamase inhibitor combinations (βL-βLICs) against KPC-producing Klebsiella pneumoniae clinical isolates 102
Totale 16.457
Categoria #
all - tutte 51.979
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.979


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.601 0 51 76 208 126 94 48 156 71 179 344 248
2022/20232.007 185 214 102 276 171 128 59 128 344 99 163 138
2023/2024826 50 96 62 88 64 173 47 62 26 73 44 41
2024/20252.638 119 361 232 218 427 153 184 127 41 168 131 477
2025/20266.143 609 622 540 454 661 335 618 212 1.156 430 290 216
2026/2027465 189 276 0 0 0 0 0 0 0 0 0 0
Totale 17.608